Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts
- PMID: 3110347
- PMCID: PMC2188636
- DOI: 10.1084/jem.166.1.129
Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts
Abstract
Normodense human peripheral blood eosinophils were isolated under sterile conditions from the 22/23 and 23/24% interfaces and the cell pellet of metrizamide gradients. After culture for 7 d in RPMI media in the presence of 50 pM biosynthetic (recombinant) human granulocyte/macrophage colony-stimulating factor (rH GM-CSF), 43 +/- 7% (mean +/- SEM, n = 8) of the cells were viable; in the absence of rH GM-CSF, no eosinophils survived. The rH GM-CSF-mediated viability was concentration dependent; increased survival began at a concentration of 1 pM, a 50% maximal response was attained at approximately 3 pM, and a maximal effect was reached at concentrations of greater than or equal to 10 pM rH GM-CSF. In the presence of rH GM-CSF and mouse 3T3 fibroblasts, 67 +/- 6% (mean +/- SEM, n = 8) of the eosinophils survived for 7 d. In a comparative analysis, there was no difference in eosinophil viability after 7 and 14 d (n = 3) in the presence of 50 pM GM-CSF and fibroblasts. Culture with fibroblasts alone did not support eosinophil survival. The addition of fibroblast-conditioned media to rH GM-CSF did not further improve eosinophil viability, indicating a primary role for GM-CSF in supporting these eosinophil cell suspensions ex vivo and a supplementary role for 3T3 fibroblasts. Eosinophils cultured for 7 d localized on density gradient sedimentation at the medium/18, 18/20, and 20/21 interfaces of metrizamide gradients, indicating a change to the hypodense phenotype from their original normodense condition. In addition, the cultured eosinophils generated approximately 2.5-fold more LTC4 than freshly isolated cells when stimulated with the calcium ionophore A23187 and manifested sevenfold greater antibody-dependent killing of S. mansoni larvae than the freshly isolated, normodense cells from the same donor. Thus we demonstrate the rH GM-CSF dependent conversion in vitro of normodense human eosinophils to hypodense cells possessing the augmented biochemical and biological properties characteristic of the hypodense eosinophils associated with a variety of hypereosinophilic syndromes. In addition, these studies provide a culture model of at least 14 d suitable for the further characterization of hypodense eosinophils.
Similar articles
-
Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.J Clin Invest. 1988 Jun;81(6):1986-92. doi: 10.1172/JCI113547. J Clin Invest. 1988. PMID: 3133397 Free PMC article.
-
IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.J Immunol. 1989 Oct 1;143(7):2311-6. J Immunol. 1989. PMID: 2506282
-
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.J Immunol. 1986 Nov 15;137(10):3290-4. J Immunol. 1986. PMID: 3095427
-
Control of eosinophilia.Int Arch Allergy Appl Immunol. 1991;94(1-4):122-6. doi: 10.1159/000235342. Int Arch Allergy Appl Immunol. 1991. PMID: 1937865 Review.
-
Human eosinophil heterogeneity.Ric Clin Lab. 1986 Jul-Sep;16(3):429-34. doi: 10.1007/BF02886737. Ric Clin Lab. 1986. PMID: 3544158 Review.
Cited by
-
Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.Arch Dermatol Res. 1989;281(5):304-9. doi: 10.1007/BF00412972. Arch Dermatol Res. 1989. PMID: 2552935
-
Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.J Clin Invest. 1991 Jun;87(6):1958-63. doi: 10.1172/JCI115222. J Clin Invest. 1991. PMID: 1645746 Free PMC article.
-
Cytokine/anti-cytokine therapy - novel treatments for asthma?Br J Pharmacol. 2011 May;163(1):81-95. doi: 10.1111/j.1476-5381.2011.01219.x. Br J Pharmacol. 2011. PMID: 21232048 Free PMC article. Review.
-
Eosinophils in the 1990s: new perspectives on their role in health and disease.Postgrad Med J. 1994 Aug;70(826):536-52. doi: 10.1136/pgmj.70.826.536. Postgrad Med J. 1994. PMID: 7937446 Free PMC article. Review.
-
Evidence for Th2-type T helper cell control of allergic disease in vivo.Springer Semin Immunopathol. 1993;15(1):17-27. doi: 10.1007/BF00204623. Springer Semin Immunopathol. 1993. PMID: 8103244 Review. No abstract available.